Key facts
- It has raised $109.9M; the latest was Later Stage VC in Sep 2024.
- Notable investors include Arch Grants, Arieli Group, Soleus Capital, Elron Ventures, Evergreen Venture Partners — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Notal Vision
- ·The full record, as it builds
Funding rounds
No funding rounds for Notal Vision are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Notal Vision
Provider of digital health services and remote diagnostics intended for managing and detecting the progression of retinal diseases. The company extends eye disease management from the clinic to the home, employing patient-operated diagnostic devices such as daily vision testing or home optical coherence tomography with proprietary artificial intelligence algorithms, enabling healthcare providers in practice and patients to receive precision medicine and improve outcomes through timely treatment decisions.
- Sector
- Healthcare
- HQ
- Manassas, VA, United States
- Founded
- 2000
- Employees
- 86
- Website
- notalvision.com/
- Ownership
- Privately Held (backing)
Notal Vision doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Notal Vision shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Notal Vision in its N-PORT filings yet. We sweep new filings monthly.